BioOra is proud to be New Zealand's first Chimeric Antigen Receptor CAR T-cell manufacturing company. At the forefront of cell therapy innovation, we are currently manufacturing for a Phase II clinical trial and advancing toward large scale commercial production. Our goal is to revolutionise cancer immunotherapy by automating and scaling the production of CAR T-cells, to deliver this life-saving technology at a fraction of standard costs and time.